Filing Flows › Lipocine (LPCN) › Recalls, complaints & regulation
Lipocine (LPCN): clinical trials
Lipocine (LPCN) beyond its filings: 1 active clinical trial.
Lipocine's latest quarter
Lipocine, Q3 2026: revenue $2.3M (20× year over year), operating margin -37.9%, net loss $666K, operating cash flow −$1.8M. The chart follows the revenue to costs, profit and cash.
Questions
How many clinical trials does Lipocine have?
1 active study on ClinicalTrials.gov, 1 in phase 3.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.